Quadrivalent human papillomavirus vaccine effectiveness after 12 years in Madrid (Spain)
JJ Hernandez-Aguado, DÁ Sánchez Torres… - Vaccines, 2022 - mdpi.com
A fully government-funded human papillomavirus (HPV) vaccination program started in
2007 in Spain (only 11–14-year-old girls). The first of those vaccinated cohorts, with the …
2007 in Spain (only 11–14-year-old girls). The first of those vaccinated cohorts, with the …
Long-term clinical impact of introducing a human papillomavirus 16/18 AS04 adjuvant cervical cancer vaccine in Spain
A Gauthier, V Martín-Escudero, L Moore… - … European Journal of …, 2008 - academic.oup.com
Background: Human papillomavirus (HPV) epidemiology and screening practices vary
considerably between countries and specific analyses are required to estimate the impact of …
considerably between countries and specific analyses are required to estimate the impact of …
Reduction in vaccine HPV type infections in a young women group (18–25 years) five years after HPV vaccine introduction in Colombia
AL Combita, V Reyes, D Puerto, R Murillo… - Cancer Prevention …, 2022 - AACR
In Colombia, the human papillomavirus (HPV) vaccine was launched in 2012 in the context
of a school-based national vaccination program targeting girls ages 9 to 14 and offering …
of a school-based national vaccination program targeting girls ages 9 to 14 and offering …
Estimating the epidemiological impact and cost-effectiveness profile of a nonavalent HPV vaccine in Spain
J De La Fuente, JJ Hernandez Aguado… - Human vaccines & …, 2019 - Taylor & Francis
Human papillomavirus (HPV) is one of the main causes of infection-related cancer. The
bivalent vaccine (2vHPV)(16/18) and quadrivalent (6/11/16/18) HPV vaccine (4vHPV) have …
bivalent vaccine (2vHPV)(16/18) and quadrivalent (6/11/16/18) HPV vaccine (4vHPV) have …
Final analysis of a 14-year long-term follow-up study of the effectiveness and immunogenicity of the quadrivalent human papillomavirus vaccine in women from four …
SK Kjaer, M Nygård, K Sundström, J Dillner… - …, 2020 - thelancet.com
Background The quadrivalent human papillomavirus (qHPV) vaccine prevented vaccine
HPV type-related infection and disease in young women in the 4-year FUTURE II efficacy …
HPV type-related infection and disease in young women in the 4-year FUTURE II efficacy …
Prevalence of high-risk HPV genotypes, categorised by their quadrivalent and nine-valent HPV vaccination coverage, and the genotype association with high-grade …
M Paz-Zulueta, L Álvarez-Paredes, JC Rodríguez Díaz… - BMC cancer, 2018 - Springer
Background The new nine-valent vaccine against human papillomavirus (HPV) includes the
four HPV genotypes (6, 11, 16, and 18) that are targeted by the older quadrivalent HPV …
four HPV genotypes (6, 11, 16, and 18) that are targeted by the older quadrivalent HPV …
Prevalence and type distribution of high‐risk human papillomavirus infection in women undergoing voluntary cervical cancer screening in Italy
A Agarossi, E Ferrazzi, F Parazzini… - Journal of medical …, 2009 - Wiley Online Library
The aim of this survey was to assess the prevalence and distribution of oncogenic human
papillomavirus (HPV) genotypes in women who underwent screening for cervical cancer in …
papillomavirus (HPV) genotypes in women who underwent screening for cervical cancer in …
[HTML][HTML] Effectiveness of bivalent and quadrivalent human papillomavirus vaccination in Luxembourg
Abstract Background In Luxembourg, the human papillomavirus (HPV) vaccination program
introduced in 2008, provided either bivalent (BV) or quadrivalent (QV) vaccines to girls aged …
introduced in 2008, provided either bivalent (BV) or quadrivalent (QV) vaccines to girls aged …
Human papillomavirus vaccine. Efficacy and safety
L Bruni, B Serrano, X Bosch… - … y microbiologia clinica, 2015 - europepmc.org
Human papillomavirus (HPV) related disease remains a major cause of morbidity and
mortality worldwide. Prophylactic vaccines have been recognized as the most effective …
mortality worldwide. Prophylactic vaccines have been recognized as the most effective …
Direct, indirect and total effectiveness of bivalent HPV vaccine in women in Galicia, Spain
MJ Purriños-Hermida, MI Santiago-Pérez, M Treviño… - PLoS …, 2018 - journals.plos.org
Bivalent human papillomavirus (HPV) vaccine was incorporated into the childhood
vaccination calendar in Galicia, Spain in 2008. The objectives of this study were to estimate …
vaccination calendar in Galicia, Spain in 2008. The objectives of this study were to estimate …